Forums before death by AOL, social media and spammers... "We can't have nice things"
|    alt.politics    |    General politics chatter    |    94,851 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 92,960 of 94,851    |
|    Lupov Henley to Mitchell Holman    |
|    Re: GOP Tells Florida To Pound Sand (2/2    |
|    17 Dec 25 14:58:04    |
      [continued from previous message]              >> their bill.       >       >       > How is that different from insurance companies?              How's it not? It's different in several key ways that promote choice,       efficiency, and better care—things a government monopoly can't match.              Competition and innovation: Private insurers compete for customers,       which drives them to innovate, negotiate better rates with providers,       and offer tailored plans (e.g., low-deductible for families or HSAs for       healthy individuals). A government single-payer system eliminates       competition, leading to stagnation—like how the VA system has faced       scandals over inefficiency and poor quality.              Choice and personalization: You pick your plan based on your needs,       budget, and preferences, with options for add-ons like dental or vision.       Single-payer is one-size-fits-all, dictated by bureaucrats, often       resulting in rationing and long wait times. See Canada's system where       median wait times for specialist treatment are over 27 weeks vs. under 4       weeks in the US for similar care.              Incentives for quality: Profits motivate insurers to approve claims       quickly and invest in preventive care to avoid bigger payouts later.       Denials happen, but competition and regulations (like ACA protections)       keep them in check. Government systems prioritize budgets over patients,       leading to denied or delayed care. Look at the UK's NHS, where over 7       million people are on waiting lists as of late 2025.              Who pays and how: while premiums spread risk, they're voluntary and tied       to market forces, not mandatory taxes that hit everyone regardless. US       per-capita spending is high, but we lead in medical innovation (e.g.,       new drugs and tech) because private incentives fund R&D—over 50% of       global pharma innovation comes from here.              With polls showing that only 35% favor a fully government-run system,       with 65% preferring private options or a mix, people want reform, not a       takeover that could raise taxes by trillions and limit access.              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca